An Observational Study of Patients With Chronic Liver Disease

Target PharmaSolutions, Inc.

Summary

TARGET-Liver Disease (TARGET-LD) is an observational research study to conduct a comprehensive review of outcomes for patients with chronic liver disease (CLD).

Eligibility

Age range: 18+ years
Sex: All
Healthy volunteers: No

Detailed criteria

Inclusion Criteria: Disease Cohort •Adult\* patients at the time of enrollment with a diagnosis of CLD/cirrhosis by ICD-10 code in the EHR interface Engaged Cohort * Adult\* patients diagnosed and managed for CLD/cirrhosis invited to participate * Ability to provide written informed consent Exclusion Criteria: Disease Cohort * Death * Manual removal (sponsor or site request) * No EHR interface encounter \> 3 years. Engaged Cohort * Patient expressed desire to withdraw consent to complete PROs * Failure to complete PROs within 24 weeks of initial invitation * Greater than 24 months lap…

Interventions

Other
Observational
Observational

Locations (10)

Keck School of Medicine of USC
Los Angeles, California
Stanford Medicine
Redwood City, California
Georgetown Medstar Transplant Institute
Washington D.C., District of Columbia
Rush University Medical Center
Chicago, Illinois
Columbia University Irving Medical Center/ New York Presbyterian Hospital
New York, New York
Atrium Health Center for Liver Disease and Transplant
Charlotte, North Carolina